Tumor-induced osteomalacia is a rare condition characterized by tumor-related renal phosphate wasting and abnormal vitamin D metabolism, which results in progressively worsening weakness, bone ...

Tumour-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a rare paraneoplastic disorder caused by tumours that secrete fibroblast growth factor 23. Clinically, TIO is associated ...

Osteomalacia is a weakening of the bones that can lead to serious health complications. Take a look at the causes, symptoms, and diagnosis.

Got bones that bend and break easily? WebMD explains more about osteomalacia, the “soft bone” disease.

OSTEOMALACIA is a generalized disease of bone characterized by lack of calcification of a presumably normal osteoid matrix. The chemical changes in the serum are usually diagnostic and consist of a ...

Mutations in fibroblast growth factor 23 (FGF-23) cause autosomal dominant hypophosphatemic rickets. Clinical and laboratory findings in this disorder are similar to those in oncogenic osteomalacia ...

Osteomalacia is a condition leading to softening of the bones due to defective deposition of minerals, especially calcium. It is mainly caused by the lack of vitamin D which is obtained from sunlight.

Chest, ankle, and hip pain are presented in a previously healthy 32-year-old man whose unusual, persistent musculoskeletal symptoms pointed to tumor-induced osteomalacia. How is this diagnosis made?

In a recent market intelligence analysis by Data Bridge Market Research, the Osteomalacia Treatment Market was thoroughly examined. The recently released report utilizes an attractive format to ...

Long-term therapy with some antiepileptic drugs and antibiotics can cause osteomalacia, which is usually the result of vitamin D deficiency. University of Washington researchers now report in the ...